Pharma body opposes entry curbs on medical representatives, seeks rethink

The Indian Pharmaceutical Alliance (IPA) voices concerns over the government's ban on medical representatives in central hospitals, arguing it hinders knowledge dissemination and patient care. IPA urges a structured engagement model, citing potential impacts on pharmaceutical growth, job losses, and the introduction of new therapies. They emphasize the role of MRs in sharing crucial information and supporting evidence-based practice.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1F048lB
via IFTTT